Seeking men and women over 18 years of age to determine the effectiveness of the Moderna COVID-19 vaccine in this patients who have had a solid organ transplant, kidney or liver, and health volunteers.
Participants in this trial will be randomly assigned to receive either the investigational vaccine or a placebo (looks like the vaccine, but doesn't contain medication). There will be approximately 7 clinic visits over 13 months.
What we're hoping for
To evaluate the safety and effectiveness of the mRNA-1273 vaccine for the prevention of COVID-19 in patients who have had a solid organ transplant, kidney or liver. The effectiveness of the mRNA-1273 study vaccine is not known in this population.
ClinicalTrials.gov Identifier: NCT04860297